New York State Common Retirement Fund
VERV

New York State Common Retirement Fund’s Verve Therapeutics VERV Stock Holding History

New York State Common Retirement Fund’s Portfolio VERV Stock Details VERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-12,855
Closed -$144K – 3233
2025
Q2 		$144K Sell
12,855
-8,900
-41% -$50.7K ﹤0.01% 2391
2025
Q1 		$99.4K Hold
21,755
– – ﹤0.01% 2516
2024
Q4 		$123K Hold
21,755
– – ﹤0.01% 2509
2024
Q3 		$105K Hold
21,755
– – ﹤0.01% 2561
2024
Q2 		$106K Sell
21,755
-375
-2% -$2.36K ﹤0.01% 2731
2024
Q1 		$294K Buy
22,130
+479
+2% +$6.35K ﹤0.01% 2286
2023
Q4 		$302K Sell
21,651
-1,382
-6% -$17.1K ﹤0.01% 2287
2023
Q3 		$305K Buy
23,033
+199
+0.9% +$3.2K ﹤0.01% 2239
2023
Q2 		$428K Sell
22,834
-2,164
-9% -$36K ﹤0.01% 2156
2023
Q1 		$360K Sell
24,998
-5,687
-19% -$111K ﹤0.01% 2343
2022
Q4 		$594K Buy
30,685
+43
+0.1% +$1.14K ﹤0.01% 2227
2022
Q3 		$1.05M Buy
30,642
+3,681
+14% +$117K ﹤0.01% 1946
2022
Q2 		$412K Buy
26,961
+114
+0.4% +$1.77K ﹤0.01% 2444
2022
Q1 		$613K Sell
26,847
-2,660
-9% -$76K ﹤0.01% 2319
2021
Q4 		$1.09M Buy
29,507
+13,148
+80% +$552K ﹤0.01% 2079
2021
Q3 		$769K Buy
+16,359
New +$962K ﹤0.01% 2235

Other funds holding VERV

GCM
Greenland Capital Management New York $787M AUM 40.68% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
BIG
Brooklyn Investment Group Brooklyn, New York $3.2B AUM 26.32% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

New York State Common Retirement Fund's VERV Position: Q3 2025 in Review

New York State Common Retirement Fund sold out of Verve Therapeutics (VERV) in Q3 2025, closing a stake of 12,855 shares — an estimated $144K sold.

New York State Common Retirement Fund first reported a position in VERV in Q3 2021 and held it in 16 quarters. The position peaked at $1.09M in Q4 2021. 6 funds tracked by Wall St. Rank hold VERV as of Q3 2025.

  • New York State Common Retirement Fund reported no remaining Verve Therapeutics position as of Q3 2025 after selling out during the quarter.
  • New York State Common Retirement Fund sold 12,855 Verve Therapeutics shares in Q3 2025, an estimated $144K.
  • New York State Common Retirement Fund first reported a position in Verve Therapeutics in Q3 2021 and held it in 16 quarters.
  • New York State Common Retirement Fund's Verve Therapeutics position peaked at $1.09M in Q4 2021.
  • 6 funds tracked by Wall St. Rank held Verve Therapeutics as of Q3 2025.

Based on New York State Common Retirement Fund's 13F filing for Q3 2025, filed 3 Nov 2025.